title: Relationship between total homocysteine, total cholesterol and creatinine levels in overt hypothyroid patients.
abstract: Hypothyroidism is associated with an increased risk for cardiovascular disease, which can not be fully explained by the atherogenic lipid profile, particularly total cholesterol and LDL-C, and other pathogenic factors may be involved. Plasma total homocysteine (tHcy) is an independent risk factor for cardiovascular disease and accelerated atherosclerosis. The aim of this study was to investigate the serum total homocysteine (tHcy) levels and its relation to total cholesterol, creatinine and thyroid hormones fT3, fT4 and TSH levels in overt hypothyroid patients compared to control subjects. In this study thirty recently diagnosed, non-treated overt hypothyroid patients (f=27, m=3) and twenty normal volunteers control (f=18, m=2) were included and subjected to determination of serum tHcy by enzyme immunoassay (EIA) technique, fT3, fT4 and TSH by Elecsys cobas e 601 analyzer, total cholesterol by enzymatic method and creatinine by kinetic method. The data was statistically analysed by SPSS-10 and p values less than 0.05 were considered significant.Our results showed that there were a significant increase of tHcy, TSH, T.cholesterol and creatinine levels by 113%, 12-folds, 58% and 54%, respectively, and a significant decrease of fT4 and fT3 levels by 49.6% and 56.4% , respectively, in hypothyroid patients than in control group. For tHcy (Mean±SD, 24.45±5.50 μmol/l vs 11.48±3.03 μmol/l, respectively; P < 0.001). tHcy was significantly positively correlated with TSH, creatinine and age and negatively correlated with free thyroxine (fT4) and no significant correlations with fT3 and T.cholesterol. In conclusion, our study confirmed the observation of elevated serum tHcy, T.cholesterol and creatinine in overt hypothyroidism and the presence of an inverse relation between tHcy with fT4 and a positive relation with TSH.
authors.affiliation: Haematology Department, Faculty of Medicine and Health Sciences, Sana'a University, Sana'a, Yemen.
authors.forename: Saleh A
authors.initials: SA
authors.lastname: Bamashmoos
authors.forename: Mohammed Ak
authors.initials: MA
authors.lastname: Al-Nuzaily
authors.forename: Ali M
authors.initials: AM
authors.lastname: Al-Meeri
authors.forename: Faisal Hh
authors.initials: FH
authors.lastname: Ali
keywords: Atherosclerosis; Cardiovascular disease; Cholesterol; Creatinine; Homocysteine; Hypothyroidism; Thyroid stimulating hormone; Thyroxine; Triiodothyronine
references.citation: Eur J Biochem. 2001 Jul;268(14):3871-82
references.pmid: 11453979
references.citation: Ann Intern Med. 2000 Feb 15;132(4):270-8
references.pmid: 10681281
references.citation: N Engl J Med. 1995 Dec 7;333(23):1522-7
references.pmid: 7477166
references.citation: JAMA. 1995 Nov 15;274(19):1526-33
references.pmid: 7474221
references.citation: Vascul Pharmacol. 2010 Mar-Apr;52(3-4):151-6
references.pmid: 19808101
references.citation: J Clin Endocrinol Metab. 2000 Mar;85(3):1049-53
references.pmid: 10720038
references.citation: Semin Thromb Hemost. 2000;26(3):263-79
references.pmid: 11011844
references.citation: J Am Soc Nephrol. 1999 Jan;10(1):164-6
references.pmid: 9890323
references.citation: Am J Epidemiol. 2001 Jul 15;154(2):150-4
references.pmid: 11447048
references.citation: J Biol Chem. 1989 May 25;264(15):8575-9
references.pmid: 2722789
references.citation: Am J Kidney Dis. 1996 Feb;27(2):195-8
references.pmid: 8659492
references.citation: Biochim Biophys Acta. 1998 Aug 28;1393(2-3):317-24
references.pmid: 9748642
references.citation: J Atheroscler Res. 1963 Jul-Aug;3:295-300
references.pmid: 14051795
references.citation: J Thromb Haemost. 2005 Feb;3(2):292-9
references.pmid: 15670035
references.citation: Int J Epidemiol. 1995 Aug;24(4):704-9
references.pmid: 8550266
references.citation: Annu Rev Nutr. 1999;19:217-46
references.pmid: 10448523
references.citation: Int J Endocrinol. 2012;2012:109797
references.pmid: 22505888
references.citation: Presse Med. 2001 Sep 1;30(24 Pt 1):1193-8
references.pmid: 11577594
references.citation: JAMA. 1995 Oct 4;274(13):1049-57
references.pmid: 7563456
references.citation: Ann Intern Med. 1968 Feb;68(2):338-44
references.pmid: 5713917
references.citation: Clin Endocrinol (Oxf). 2001 Feb;54(2):197-204
references.pmid: 11207634
references.citation: Circulation. 1993 May;87(5):1435-41
references.pmid: 8490997
references.citation: Endocr J. 2006 Feb;53(1):119-24
references.pmid: 16543681
references.citation: Nephron. 2001 Jul;88(3):264-7
references.pmid: 11423759
references.citation: Endokrynol Pol. 2005 Mar-Apr;56(2):194-202
references.pmid: 16335688
references.citation: Kidney Int. 1997 Aug;52(2):495-502
references.pmid: 9264008
references.citation: J Clin Endocrinol Metab. 1992 Sep;75(3):721-5
references.pmid: 1517361
references.citation: Endocr J. 2007 Jun;54(3):471-6
references.pmid: 17464093
references.citation: BMC Cardiovasc Disord. 2006 Sep 26;6:38
references.pmid: 17002799
references.citation: J Nephrol. 2002 Jul-Aug;15(4):414-21
references.pmid: 12243373
references.citation: Metabolism. 1998 Jan;47(1):89-93
references.pmid: 9440483
references.citation: Clin Endocrinol (Oxf). 2005 Apr;62(4):423-7
references.pmid: 15807872
references.citation: Arch Biochem Biophys. 1995 Nov 10;323(2):404-8
references.pmid: 7487105